What Happens in Chronic Kidney Disease (CKD)
CKD is a progressive condition where the kidneys gradually lose their ability to filter waste and maintain homeostasis, leading to a cascade of metabolic, cardiovascular, hematologic, and bone complications that significantly increase morbidity and mortality. 1, 2
Core Pathophysiological Changes
Kidney Function Decline
- Reduced glomerular filtration rate (GFR) is the hallmark, defined as GFR <60 mL/min/1.73 m² for ≥3 months 3, 4
- Albuminuria (≥30 mg/g creatinine) indicates kidney damage and predicts both CKD progression and cardiovascular events 5, 6
- Progressive fibrosis, tubular atrophy, and interstitial inflammation characterize the pathological changes regardless of initial cause 7
Timeline and Progression
In type 1 diabetes, CKD typically develops after 10 years of disease duration, while in type 2 diabetes it may be present at diagnosis 6, 8. The disease progresses through five stages based on eGFR, with each stage carrying increasing risk 1, 3.
Major Clinical Manifestations and Complications
Cardiovascular Disease (The Leading Cause of Death)
People with CKD are 5-10 times more likely to die from cardiovascular disease than to progress to kidney failure 2. The mechanisms include:
- Vascular calcification affecting coronary arteries, myocardium, and cardiac valves, leading to ischemic heart disease, arrhythmias, and congestive heart failure 9
- Left ventricular hypertrophy from increased cardiac output and mineral stress 10
- Accelerated atherosclerosis driven by inflammation, oxidative stress, and uremic toxins 2, 11
Anemia
Normocytic, normochromic anemia occurs due to insufficient erythropoietin production by diseased kidneys 10. This leads to:
- Decreased tissue oxygen delivery
- Cardiac enlargement and ventricular hypertrophy
- Decreased cognition and mental acuity
- Impaired quality of life and increased mortality 10
Contributing factors include iron deficiency from blood loss, shortened red blood cell survival, and chronic inflammation 10.
Mineral and Bone Disorder (CKD-MBD)
Disturbances begin in early CKD stages and affect >50% of patients with moderate-to-severe disease 9. The pathophysiology involves:
- Phosphate retention and positive phosphate balance (earliest abnormality)
- Elevated FGF-23 and sclerostin levels
- Calcitriol (vitamin D) deficiency
- Secondary hyperparathyroidism from bone resistance to PTH
- Bone disease ranging from high turnover to adynamic bone disease 9
Clinical consequences include bone pain, fractures, deformities, myopathy, tendon ruptures, and soft tissue calcification affecting lungs, heart, and blood vessels 9.
Metabolic and Electrolyte Abnormalities
- Hyperkalemia from reduced potassium excretion
- Metabolic acidosis from impaired acid excretion
- Fluid overload and hypertension
- Uremic toxin accumulation affecting multiple organ systems 2, 11
Neurological Complications
Cognitive impairment occurs across all CKD stages, independent of age 12. Mechanisms include:
- Microvascular disease and blood-brain barrier disruption
- Uremic toxins
- Oxidative stress and neuroinflammation
- Dialysis-related hemodynamic changes in advanced stages 12
Other Systemic Effects
- Decreased quality of life that worsens as GFR declines 2
- Lethargy, pruritus, loss of appetite
- Altered menstrual cycles and sexual dysfunction
- Impaired immune function increasing infection risk 10
- Growth retardation in children 10
Common Pathways Leading to Progression
Regardless of initial cause (diabetes, hypertension, glomerulonephritis, etc.), CKD follows common pathways 7, 11:
- Tubulointerstitial hypoxia from reduced blood flow
- Proteinuria causing direct tubular toxicity
- Chronic inflammation and oxidative stress
- Progressive fibrosis with myofibroblast activation
- Nephron loss creating a vicious cycle of hyperfiltration in remaining nephrons 7, 11
Critical Clinical Pitfalls
- Asymptomatic early stages: Many patients have no symptoms until advanced disease, making screening essential 2
- Cardiovascular death precedes kidney failure: Focus must be on cardiovascular risk reduction, not just slowing GFR decline 2
- Multisystem involvement: CKD is not just a kidney problem—it affects every organ system and requires comprehensive management 9, 4
- Inequitable access: Disadvantaged populations bear disproportionate burden with less access to early intervention 2